Drug Approval | April 15, 2022
Sandoz launches generic brimonidine tartrate eyedrop in US
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
The groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse backgrounds by 2027
Data to be presented at the 2022 AACR annual meeting highlights the unique nature of post-chemotherapy derived gene expression signatures in stratifying patient outcomes
Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting
During her tenure at the University of South Florida Dr. Hunter was responsible for managing the patent portfolio associated with Alzamend’s two product candidates, AL001 and AL002
An estimated 21 million American women experience BV
Subscribe To Our Newsletter & Stay Updated
